POM-V Prescription Required Companion Animal

Fortekor 2.5 mg Tablets for Cats and Dogs

Active ingredient: Benazepril Hydrochloride

Form

Tablet

Species

Cats Dogs

Manufacturer

Elanco GmbH

VMD MA No.

52127/3008

What it's used for

Cats: Reduction of proteinuria associated with chronic kidney disease.

Full indications, dosage and side effects ↓

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Benazepril Hydrochloride

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Fortekor 2.5 mg Tablets for Cats and Dogs — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

Cats:
Reduction of proteinuria associated with chronic kidney disease.

This veterinary medicinal product
duration of treatment is unlimited.
This product is flavoured and is taken voluntarily by most dogs and cats.
Dogs:
This veterinary medicinal product should be administered at a minimum dose of 0.25 mg
(range 0.25-0.5) benazepril hydrochloride/kg body weight once daily, according to the
following table:
2.5 mg tablet strengthWeight of
dog
(kg)
Standard
dose
Double dose2.5 - 50.5 tablet1 tablet>5 - 101 tablet2 tablets
The dose may be doubled, still administered once daily, to a minimum dose of 0.5 mg/kg
(range 0.5-1.0), if judged clinically necessary and advised by the veterinary surgeon.
Cats:
This veterinary medicinal product should be administered at a minimum dose of 0.5 mg
(range 0.5-1.0) benazepril hydrochloride/kg body weight once daily according to the
following table:
Weight of cat
(kg)
2.5 mg tablet strength2.5 – 51 tablet>5 – 102 tablets

Do not use in cases of hypersensitivity to the active substance or to any of the excipients.
Do not use in cases of hypotension, hypovolaemia, hyponatraemia or acute renal failure.
Do not use in cases of cardiac output failure due to aortic or pulmonary stenosis.
Do not use during pregnancy or lactation (section 3.7).

Dogs:
Rare
(1 to 10 animals / 10,000 animals
treated):
Diarrhoea, Vomiting,
Anorexia, Fatigue
Very rare
(<1 animal / 10,000 animals treated,
including isolated reports):
Elevated creatinine
,
Incoordination
In dogs with chronic kidney disease, the product may increase plasma creatinine
concentrations at the start of therapy. A moderate increase in plasma creatinine
concentrations following administration of ACE inhibitors is compatible with the reduction
in glomerular hypertension induced by these agents and is therefore not necessarily a
reason to stop therapy in the absence of other signs.
In double-blind clinical trials in dogs with congestive heart failure, the veterinary medicinal
product was well tolerated with an incidence of adverse reactions lower than observed in
placebo-treated dogs.
Cats:
Rare
(1 to 10 animals / 10,000 animals
treated):
Diarrhoea, Emesis,
Anorexia, Dehydration, Lethargy
Very rare
(<1 animal / 10,000 animals treated,
including isolated reports):
Elevated creatinine
,
Increased appetite, Weight gain
In cats with chronic kidney disease, the product may increase plasma creatinine
concentrations at the start of therapy. A moderate increase in plasma creatinine
concentrations following administration of ACE inhibitors is compatible with the reduction
in glomerular hypertension induced by these agents and is therefore not necessarily a
reason to stop therapy in the absence of other signs.

Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or its local representative or the national
competent authority via the national reporting system. See package leaflet for respective
contact details.

None.

Special precautions for safe use in the target species:
No evidence of renal toxicity of the veterinary medicinal product has been observed (in
dogs or cats) during clinical trials, however, as is routine in cases of chronic kidney
disease, it is recommended to monitor plasma creatinine, urea and erythrocyte counts
during therapy.
The efficacy and safety of the veterinary medicinal product has not been established in
dogs and cats below 2.5 kg body weight.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals:
Angiotensin converting enzyme (ACE) inhibitors have been found to affect the unborn child
during pregnancy in humans. Pregnant women should take special care to avoid
accidental oral exposure.
Wash hands after use.
In case of accidental oral ingestion, seek medical advice immediately and show the
package leaflet or the label to the physician.
Special precautions for the protection of the environment:
Not applicable.

In dogs with congestive heart failure, the veterinary medicinal product has been given in
combination with digoxin, diuretics, pimobendan and anti-arrhythmic veterinary medicinal
products without demonstrable adverse interactions.
In humans, the combination of ACE inhibitors and non-steroidal anti-inflammatory drugs
(NSAIDs) can lead to reduced anti-hypertensive efficacy or impaired renal function. The
combination of the product and other anti-hypertensive agents (e.g. calcium channel
blockers, -blockers or diuretics), anaesthetics or sedatives may lead to additive
hypotensive effects. Therefore, concurrent use of NSAIDs or other medications with a
hypotensive effect should be considered with care. Renal function and signs of
hypotension (lethargy, weakness etc) should be monitored closely and treated as
necessary.
Interactions with potassium preserving diuretics like spironolactone, triamterene or
amiloride cannot be ruled out. It is recommended to monitor plasma potassium levels
when using the veterinary medicinal product in combination with a potassium sparing
diuretic because of the risk of hyperkalaemia.

Do not store above 25 °C.
Store in a dry place.
Each time an unused half tablet is stored, it should be returned to the open blister space
inserted back into the cardboard box and kept in a safe place out of the sight and reach of
children.

Not applicable.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.